Subscribe to Email Notifications
Sign up here to get blog posts delivered to your inbox.
- Email Notifications
- Entries (RSS)
- Comments (RSS)
- PostScript is a group blog, and a forum for many different opinions on prescription drug issues. The views expressed do not necessarily reflect those of Community Catalyst or of other PostScript authors.
Archives
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Categories
- academic detailing (10)
- Academic Medical Centers (41)
- Boston University School of Medicine (2)
- Brown University (1)
- Emory University (4)
- Harvard (5)
- Memorial Sloan-Kettering Cancer Center (1)
- Mt. Sinai School of Medicine (2)
- University of California – Davis (1)
- University of California San Francisco (4)
- University of New Mexico (1)
- University of Texas Southwestern Medical Center (1)
- University of Toronto (1)
- Vanderbilt (1)
- brand name drugs (35)
- clinical trials (14)
- ENHANCE (1)
- postmarket surveillance (3)
- comparative effectiveness review (3)
- conflict of interest (40)
- Congress (29)
- U.S. House of Representatives (13)
- U.S. Senate (17)
- Continuing Medical Education (24)
- drug safety (1)
- evidence-based medicine (3)
- FDA (55)
- EthicAd (1)
- FDA Amendments Act of 2007 (2)
- PDUFA (3)
- ghostwriting (6)
- gifts/disclosure (35)
- health reform (8)
- medical devices (3)
- medical journals (18)
- Medicare (5)
- NIH (8)
- nurse practitioners (3)
- off-label prescribing (18)
- Pfizer (13)
- pharmaceutical companies (71)
- direct-to-consumer advertising (12)
- drug reps (28)
- Eli Lilly (9)
- GlaxoSmithKline (7)
- Merck (16)
- Schering-Plough (5)
- Wyeth Pharmaceuticals (6)
- pharmaceutical supply chain (11)
- PhRMA (12)
- Physician Payments Sunshine Act (19)
- Prescription Access Litigation (9)
- prescription data-mining (18)
- professional medical associations (32)
- states (27)
- Connecticut (3)
- Florida (2)
- Maine (1)
- Massachusetts (14)
- Minnesota (4)
- New Hampshire (7)
- Uncategorized (92)
- Weekly Reader (25)
Blogroll
- A Healthy Blog
- Behind Online Pharma
- GoozNews
- Health Care Renewal
- Hooked: Ethics, Medicine and Pharma
- National Physicians Alliance
- Pharma Marketing Blog
- Prescription Access Litigation
- Running a Hospital
- Scientific Misconduct
- The Carlat Psychiatry Blog
- The Health Care Blog
- White Coat Notes
- WSJ Health Blog